Somatic mutations are present in all members of the AKT family in endometrial carcinoma
Open Access
- 8 September 2009
- journal article
- letter
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 101 (7), 1218-1219
- https://doi.org/10.1038/sj.bjc.6605301
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomasBritish Journal of Cancer, 2009
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences of the United States of America, 2009
- Drug discovery approaches targeting the PI3K/Akt pathway in cancerOncogene, 2008
- Drug-sensitiveFGFR2mutations in endometrial carcinomaProceedings of the National Academy of Sciences, 2008
- PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequencesCancer Letters, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial CarcinomaCancer Research, 2005
- Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.2001
- PTEN Expression in Breast and Endometrial Cancer: Correlations with Steroid Hormone Receptor StatusPathobiology, 2001
- PTEN1 is frequently mutated in primary endometrial carcinomasNature Genetics, 1997